These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 15599804

  • 1. The past, present and future of antiviral drug discovery.
    Littler E.
    IDrugs; 2004 Dec; 7(12):1104-12. PubMed ID: 15599804
    [Abstract] [Full Text] [Related]

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 3. New antivirals and drug resistance.
    Colman PM.
    Annu Rev Biochem; 2009 Dec; 78():95-118. PubMed ID: 19254207
    [Abstract] [Full Text] [Related]

  • 4. The priorities for antiviral drug resistance surveillance and research.
    Pillay D.
    J Antimicrob Chemother; 2007 Aug; 60 Suppl 1():i57-8. PubMed ID: 17656384
    [Abstract] [Full Text] [Related]

  • 5. Current non-AIDS antiviral chemotherapy.
    Rottinghaus ST, Whitley RJ.
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):217-30. PubMed ID: 17402837
    [Abstract] [Full Text] [Related]

  • 6. Acyclic nucleoside phosphonates: a key class of antiviral drugs.
    De Clercq E, Holý A.
    Nat Rev Drug Discov; 2005 Nov; 4(11):928-40. PubMed ID: 16264436
    [Abstract] [Full Text] [Related]

  • 7. Metal chelators as antiviral agents.
    Kirschberg T, Parrish J.
    Curr Opin Drug Discov Devel; 2007 Jul; 10(4):460-72. PubMed ID: 17659488
    [Abstract] [Full Text] [Related]

  • 8. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus.
    Tsantrizos YS.
    Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464
    [Abstract] [Full Text] [Related]

  • 9. L-nucleoside enantiomers as antivirals drugs: a mini-review.
    Mathé C, Gosselin G.
    Antiviral Res; 2006 Sep; 71(2-3):276-81. PubMed ID: 16797735
    [Abstract] [Full Text] [Related]

  • 10. Oligonucleotides as antivirals: dream or realistic perspective?
    Van Aerschot A.
    Antiviral Res; 2006 Sep; 71(2-3):307-16. PubMed ID: 16621039
    [Abstract] [Full Text] [Related]

  • 11. Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases.
    Nijhuis M, van Maarseveen NM, Boucher CA.
    Handb Exp Pharmacol; 2009 Sep; (189):299-320. PubMed ID: 19048205
    [Abstract] [Full Text] [Related]

  • 12. Antiviral therapy: old and current issues.
    Antonelli G, Turriziani O.
    Int J Antimicrob Agents; 2012 Aug; 40(2):95-102. PubMed ID: 22727532
    [Abstract] [Full Text] [Related]

  • 13. Recent developments in antiviral chemotherapy.
    McKinlay MA, Otto MJ.
    Infect Dis Clin North Am; 1987 Jun; 1(2):479-93. PubMed ID: 3332799
    [Abstract] [Full Text] [Related]

  • 14. Antivirals: past, present and future.
    De Clercq E.
    Biochem Pharmacol; 2013 Mar 15; 85(6):727-44. PubMed ID: 23270991
    [Abstract] [Full Text] [Related]

  • 15. Antiviral therapies in children: has their time arrived?
    Kimberlin DW.
    Pediatr Clin North Am; 2005 Jun 15; 52(3):837-67, vii. PubMed ID: 15925665
    [Abstract] [Full Text] [Related]

  • 16. The design of drugs for HIV and HCV.
    De Clercq E.
    Nat Rev Drug Discov; 2007 Dec 15; 6(12):1001-18. PubMed ID: 18049474
    [Abstract] [Full Text] [Related]

  • 17. [Antiviral chemotherapy in pediatrics--its present and prospects].
    Arion C, Zamfirescu A, Popescu V.
    Pediatrie (Bucur); 1992 Dec 15; 41(1):46-52. PubMed ID: 1322725
    [Abstract] [Full Text] [Related]

  • 18. Looking back in 2009 at the dawning of antiviral therapy now 50 years ago an historical perspective.
    De Clercq E.
    Adv Virus Res; 2009 Dec 15; 73():1-53. PubMed ID: 19695380
    [Abstract] [Full Text] [Related]

  • 19. Perspectives on antiviral drug development.
    Wainberg MA.
    Antiviral Res; 2009 Jan 15; 81(1):1-5. PubMed ID: 18948140
    [Abstract] [Full Text] [Related]

  • 20. Phosprenyl: a novel drug with antiviral and immunomodulatory activity.
    Danilov LL, Maltsev SD, Deyeva AV, Narovlyansky AN, Sanin AV, Ozherelkov SV, Pronin AV.
    Arch Immunol Ther Exp (Warsz); 1996 Jan 15; 44(5-6):395-400. PubMed ID: 9017158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.